Amber Balazs - Concepedia

Author

Amber Balazs

Also Known As

Amber Balazs, Amber Y. S. Balazs, Balazs, Amber Y. S.

Publications

396

Citations

H-Index

Concepts

All Affiliations

Amber Balazs is an author at AstraZeneca (United States).

Amber Balazs

Publications

358

Citations

H-Index

Page 1

	Year	Citations
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD5305): A PARP1–DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs Jeffrey W. Johannes, Amber Balazs, Derek Barratt, Journal of Medicinal Chemistry	2021	129
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and Antagonist James S. Scott, Amber Balazs, Bernard Barlaam, Journal of Medicinal Chemistry	2020	109
Structural and Physicochemical Features of Oral PROTACs Markus Schade, James S. Scott, Thomas G. Hayhow, Journal of Medicinal Chemistry	2024	44
Free Ligand 1D NMR Conformational Signatures To Enhance Structure Based Drug Design of a Mcl-1 Inhibitor (AZD5991) and Other Synthetic Macrocycles Amber Balazs, Rodrigo J. Carbajo, Nichola L. Davies, Journal of Medicinal Chemistry	2019	39
Discovery of 6-Fluoro-5-{4-[(5-fluoro-2-methyl-3-oxo-3,4-dihydroquinoxalin-6-yl)methyl]piperazin-1-yl}-<i>N</i>-methylpyridine-2-carboxamide (AZD9574): A CNS-Penetrant, PARP1-Selective Inhibitor Jeffrey W. Johannes, Amber Balazs, Derek Barratt, Journal of Medicinal Chemistry	2024	22
Discovery and Optimization of Pyrazine Carboxamide AZ3246, a Selective HPK1 Inhibitor Jason D. Shields, David Baker, Amber Balazs, Journal of Medicinal Chemistry	2025	15

Page 1